Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
Recruiting · NCT07357428 · Registry updated 2026-04-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI) | Dysarthria, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, TDP-43 proteinopathy, amyotrophic lateral sclerosis, articulation disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, communication disorder, language disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, palsy, proteostasis deficiencies, quadriplegia, speech disorder, spinal cord disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2026-04-14 | NCT07357428 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Massachusetts General Hospital | 758 |
| Paradromics | 1 |
| University of California, Davis | 257 |
| University of Michigan | 394 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Massachusetts General Hospital | Boston | United States | 1015 |
| University of California, Davis | Sacramento | United States | 49 |
| University of Michigan | Ann Arbor | United States | 538 |